Spero Therapeutics, Inc. (SPRO)
2.35
+0.02
(+0.86%)
USD |
NASDAQ |
Dec 11, 16:00
2.35
0.00 (0.00%)
Pre-Market: 20:00
Spero Therapeutics Research and Development Expense (TTM): 61.71M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Omeros Corp. | 84.14M |
| GeoVax Labs, Inc. | 22.74M |
| Vistagen Therapeutics, Inc. | 49.02M |
| Daré Bioscience, Inc. | 6.616M |
| Hyperion DeFi, Inc. | 3.469M |